Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs

CONCLUSION: In our study, patients with PsA were successfully treated with both csDMARD and bDMARD monotherapy. When the biological treatments used for PsA were compared with csDMARD, it was found that biological treatments had a positive effect on both disease activity and the QoL. Combinations of csDMARDs and bDMARDs were preferred in cases in which the disease activity was still high or increased. Because of the highest efficacy of the combined treatment, we highly suggest increasing the number of patients on combined treatment.PMID:34046563 | PMC:PMC8140874 | DOI:10.46497/ArchRheumatol.2021.7874

Source: Pain Physician - May 28, 2021 Category: Anesthesiology Authors: Ya şar Keskin Kemal Nas Erkan Kili ç Betul Sargin Sevtap Acer Kasman Hakan Alkan Nilay Şahin Gizem Cengiz Nihan Cuzdan İlknur Albayrak Gezer Dilek Keskin Cevriye M ülkoğlu Hatice Resorlu Şebnem Ataman Ajda Bal Mehmet Tuncay Duruoz Okan K üçükakk Source Type: research